GPS Wealth Strategies Group’s TriSalus Life Sciences TLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-233
Closed -$1.29K 1439
2024
Q2
$1.29K Sell
233
-424
-65% -$3.6K ﹤0.01% 1243
2024
Q1
$6.41K Hold
657
﹤0.01% 950
2023
Q4
$5.55K Hold
657
﹤0.01% 963
2023
Q3
$3.36K Buy
+657
New +$5.38K ﹤0.01% 1045

Other funds holding TLSI

GPS Wealth Strategies Group's TLSI Position: Q3 2024 in Review

GPS Wealth Strategies Group sold out of TriSalus Life Sciences (TLSI) in Q3 2024, closing a stake of 233 shares — an estimated $1.29K sold.

GPS Wealth Strategies Group first reported a position in TLSI in Q3 2023 and held it in 4 quarters. The position peaked at $6.41K in Q1 2024. 32 funds tracked by Wall St. Rank hold TLSI as of Q3 2024.

  • GPS Wealth Strategies Group reported no remaining TriSalus Life Sciences position as of Q3 2024 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 233 TriSalus Life Sciences shares in Q3 2024, an estimated $1.29K.
  • GPS Wealth Strategies Group first reported a position in TriSalus Life Sciences in Q3 2023 and held it in 4 quarters.
  • GPS Wealth Strategies Group's TriSalus Life Sciences position peaked at $6.41K in Q1 2024.
  • 32 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2024.

Based on GPS Wealth Strategies Group's 13F filing for Q3 2024, filed 29 Oct 2024.